These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35694631)

  • 1. The use of Ivermectin for the treatment of COVID-19: Panacea or enigma?
    Onyeaka H; Tamasiga P; Agbara JO; Mokgwathi OA; Uwishema O
    Clin Epidemiol Glob Health; 2022; 16():101074. PubMed ID: 35694631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing the drug, ivermectin, in COVID-19: toxicological points of view.
    Shirazi FM; Mirzaei R; Nakhaee S; Nejatian A; Ghafari S; Mehrpour O
    Eur J Med Res; 2022 Feb; 27(1):21. PubMed ID: 35123559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivermectin for preventing and treating COVID-19.
    Popp M; Reis S; Schießer S; Hausinger RI; Stegemann M; Metzendorf MI; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015017. PubMed ID: 35726131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measures implemented in the school setting to contain the COVID-19 pandemic.
    Krishnaratne S; Littlecott H; Sell K; Burns J; Rabe JE; Stratil JM; Litwin T; Kreutz C; Coenen M; Geffert K; Boger AH; Movsisyan A; Kratzer S; Klinger C; Wabnitz K; Strahwald B; Verboom B; Rehfuess E; Biallas RL; Jung-Sievers C; Voss S; Pfadenhauer LM
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD015029. PubMed ID: 35037252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study.
    Teslya A; Pham TM; Godijk NG; Kretzschmar ME; Bootsma MCJ; Rozhnova G
    PLoS Med; 2020 Jul; 17(7):e1003166. PubMed ID: 32692736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin.
    Hellwig MD; Maia A
    Int J Antimicrob Agents; 2021 Jan; 57(1):106248. PubMed ID: 33259913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster Model.
    Uematsu T; Takano T; Matsui H; Kobayashi N; Ōmura S; Hanaki H
    J Antibiot (Tokyo); 2023 Aug; 76(8):481-488. PubMed ID: 37185581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus.
    Ngonghala CN; Iboi E; Eikenberry S; Scotch M; MacIntyre CR; Bonds MH; Gumel AB
    Math Biosci; 2020 Jul; 325():108364. PubMed ID: 32360770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19: The Ivermectin African Enigma.
    Guerrero R; Bravo LE; Muñoz E; Ardila EKG; Guerrero E
    Colomb Med (Cali); 2020 Dec; 51(4):e2014613. PubMed ID: 33795896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential therapeutic effects of Ivermectin in COVID-19.
    Barati N; Motavallihaghi S; Nikfar B; Chaichian S; Momtazi-Borojeni AA
    Exp Biol Med (Maywood); 2022 Aug; 247(15):1388-1396. PubMed ID: 35686662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.
    Stratil JM; Biallas RL; Burns J; Arnold L; Geffert K; Kunzler AM; Monsef I; Stadelmaier J; Wabnitz K; Litwin T; Kreutz C; Boger AH; Lindner S; Verboom B; Voss S; Movsisyan A
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD015085. PubMed ID: 34523727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of COVID-19 Management Policies Tailored to Airborne SARS-CoV-2 Transmission: Policy Analysis.
    Telles CR; Roy A; Ajmal MR; Mustafa SK; Ahmad MA; de la Serna JM; Frigo EP; Rosales MH
    JMIR Public Health Surveill; 2021 Apr; 7(4):e20699. PubMed ID: 33729168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying the Effects of Social Distancing on the Spread of COVID-19.
    Daghriri T; Ozmen O
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34071047
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.